The Access to Medicine Foundation is strengthening its research capacity and is in search of two trained pharmacists to join our team as researchers motivated to guide pharmaceutical companies to do more for the two billion people in the world without access to the medicines they need.


6 months to 1 year (with possibility of renewal)

Work experience:

At least 2 years


€2,600 - €3,300



Closing date:

Applications will be reviewed on a rolling basis

Starting date:

As soon as possible

About the Foundation

The Access to Medicine Foundation is a non-profit organisation based in Amsterdam, the Netherlands. Our mission is to stimulate and guide pharmaceutical companies to do more for the two billion people worldwide who cannot access the medicines they need. The core pillars of our work are researching how pharmaceutical companies address the affordability and accessibility of their products in low and middle-income countries, and are addressing the threat of antimicrobial resistance. To turn our research into real-world change, we engage with leading organisations, including companies, NGOs and governments.

We are looking for two researchers who are proactive, solution-oriented, self-motivated, curious, flexible, and contribute to advancing the research activities at the Foundation. To be considered for these roles you will excel as a team player who collaborates, communicates clearly and is willing to challenge peers.

What do the roles look like

The roles may include the following responsibilities:

  • Driving the research and analysis of pharmaceutical industry actions within one of the Foundation’s research programmes (the Access to Medicine Index or the Antimicrobial Resistance Benchmark);
  • Performing comparative company analysis and industry-wide trends, such as the development, maintenance and analysis of the Foundation’s pipeline and/or product portfolio databases for companies’ in scope (including quality assurance);
  • Engaging with external stakeholders as needed to develop the methodology for either research programmes;
  • Evaluating company performance in access to medicine or in antimicrobial resistance by analysing quality-controlled data obtained from research in the public domain and collected from external stakeholder organizations and supplemented by input directly from companies;
  • Collaborating efficiently with other staff members in the research team(s) and those in charge of management, communications, operations and data management and engage with company representatives, as needed;
  • Taking on additional tasks as required.

What we are looking for:

  • An individual with a pharmacy (PharmD) or medical degree;
  • Experience with pharmaceutical pipelines and products, including R&D and registration filing;
  • Strong qualitative and quantitative analytical skills - able to identify relevant trends and clinical/scientific projects of note in large data sets, to present data accurately and concisely with a sharp eye for detail;
  • Advanced skills in Excel (and Office 365 in general). Experience with SPSS or STATA is a plus;
  • Experience working with or within the pharmaceutical industry (especially in the context of low- and middle-income countries) is a plus. Being up to date on the latest developments in the pharmaceutical industry as related to R&D, antimicrobial resistance, and access issues (availability, affordability) is a plus;
  • Strong time management skills and the ability to set priorities to achieve multiple projects and deadlines, and to identify risks and opportunities and escalate these when appropriate in a timely manner to the line manager;
  • Active communicator with excellent command of English, both spoken and written (academic and media styles).

What we offer you:

  • A dynamic, innovative, international working environment;
  • Being part of the development of reports, projects and events which stimulate and guide the pharmaceutical industry to improve access to medicines in low- and middle income countries; 
  • The possibility to work in a small, dedicated team where you can learn from each other;
  • Benefits that include 25 holidays on an annual basis based on a fulltime employment, company pension scheme, holiday allowance and reimbursement of public transport to work (if living beyond 10KM from the office).

More about the Access to Medicine Foundation

Our research products, The Access to Medicine Index and the Antimicrobial Resistance Benchmark, are valued by a wide network of experts and external stakeholders including pharmaceutical companies and industry watchers, governments, international agencies such as the United Nations and World Health Organization, pharma journalists, investors and global health professionals and academics. The Foundation also publishes stand-alone studies about the pharmaceutical industry. It identifies best practices, highlights where progress is being made, and uncovers where critical action is still required.

With these tools and outreach work, the Foundation provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. Each new product brings new opportunities to stimulate change and to advance the global debate on access to medicine. Quality research and analysis are essential activities within the Access to Medicine Foundation to achieve these change making goals.

Get a sense of how our work is used in the media and across the global health community.

How to apply

Interested in this exciting opportunity? Please send your cover letter with your motivation on why you would like to join the Access to Medicine Foundation and how you think you will fit in our team, your resume, the contact details of two references (e-mail address and/or phone number), and one writing sample (i.e. published article, thesis or white paper) to Mrs Mireille Deen at

The application will not be considered unless it is complete and all supporting documentation has been provided. There will be no compensation for relocation costs.

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |